Alder shares slump despite migraine success
June 28, 2017Investors concerned over strong placebo effect
X
Alder shares slump despite migraine success
https://pharmaphorum.com/news/alder-shares-slump-despite-migraine-success/
R&D
Merck & Co hit by GoldenEye ransomware
June 28, 2017Attack overshadows surprise success for cholesterol drug
CRUK launches next phase of cancer ‘Grand Challenge’
June 22, 2017Charity launches second set of research challenges.
Clovis looks for new drugs after Rubraca success
June 20, 2017US biotech looks to bolster pipeline.
LifeArc spends Keytruda cash on R&D ignored by pharma
June 15, 2017Formerly known as MRC Technology, charity to spend Keytruda royalties on R&D considered too risky by big pharma
FDA fast-tracks Lilly/Pfizer pain drug amid opioid crisis
June 15, 2017Companies hope tanezumab offers alternative to opioids
Biotech vTv believes small molecule GLP-1 pill can take on big players
June 14, 2017Pill could be effective in diabetes, with fewer GI effects.
J&J diabetes drug hit by amputation risk
June 13, 2017Invokana produces modest CV benefit, but doubles risk of amputation
ADA to re-evaluate tweet ban after backlash
June 11, 2017ADA says photo ban is to protect intellectual property.
